Tiopurinas

The future of thiopurine pharmacogenomics

Impact of genetic polymorphisms on chemotherapy toxicity n childhood acute lymphoblastic leukemia

Individualized immunosuprression in transplant patients-potential role of pharmacogenetics

Multilocus genotypes for drug metabolizing enzymes and therapy with thiopurines in patients with ALL

Clinical pharmacogenomics of thiopurine S-methyltransferase

Assessment of TPMT activity in patients prescribed thiopurine-based drugs

Characterisation of novel defective thiopurine s-methyltransferase allelic variants

Are patients with intermediate TPMT activity at increased risk of myelosupression when

A pragmatic randomized controlled trial of TPMT genotyping to azthioprine tratment

Prospective evalaution of the pharmacogenetics of azathioprine in

Pharmacogenetics and pharmacogenomics of anticancer agents

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease

Identifying genomic ande developmental causes of adverse drug reactoins in children

Very important pharmacogene summary - thiopurine S-methyltransferase

A pharmacogenetics study of TPMT and ITPA genes detects relationship with

TPMT deficiency-two nucleotide transitions define prevalent mutant allele associated with

Regresar al Acervo